intravesical instillation therapy is constrained by drug penetration and resistance
Some of these compounds are FDA-approved, many are not
The timeline depends on the medication, dose, length of treatment, and individual response
Patient demographics such as age and gender, along with dosage, treatment duration, presenting symptoms, imaging results, causality assessment (using Naranjo scale) (Naranjo et al., 1981), acute pancreatitis management, and outcomes were extracted from the examination of medical files
conservante: sorbato potsico
It is vital to emphasize that this approach does not increase the total weekly amount of medication